Author

Amy I. Jacobs

University College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Claire Mary SmithiD· 2 shared Laura BuggiottiiD· 2 shared Maximillian N. J. WoodalliD· 2 shared Samuel EllisiD· 2 shared Angelika Kopec· 1 shared Charles M. MilleriD· 1 shared Christopher O’CallaghaniD· 1 shared Elisabeth J. RobinsoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Claire Mary SmithORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening.

Machaela Palor, Tereza Masonou, Elisabeth J. Robinson, Wenqing Chen, Samuel Ellis, Laura Buggiotti, Amy I. Jacobs, Thomas Benoist, Paolo De Coppi, Jennifer L. Rohn, Gabriele Pollara, Mario Cortina‐Borja, Maximillian N. J. Woodall, Robert E. Hynds, Rosalind Louise Smyth, , Claire Mary Smith

This study identifies neutrophil myeloperoxidase (MPO) as a biomarker for RSV severity and demonstrates its utility as a functional readout for evaluating antiviral therapies in an in vitro model.

Nature Communications · Jul 13, 2026Peer-reviewedImmunology

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infection

Samuel Ellis, Amy I. Jacobs, Shengyuan Zhang, Laura Buggiotti, Maximillian N. J. Woodall, Jila Ajeian, Helena J. Tutill, Charles M. Miller, Macheala Palor, Angelika Kopec, Elizabeth K. Haughey, Hongxia Ma, Mia Tomlinson, Rachel J. Williams, Christopher O’Callaghan, , Judith Breuer

This study evaluates antiviral drug synergy and mutational signatures of RdRp inhibitors against RSV and hPIV in epithelial cell models and primary airway cultures.

bioRxiv · Jan 13, 2026 · PreprintMicrobiology